EPISODE · May 30, 2019 · 48 MIN
Episode 25: The Story of Cognetivity and AI Dementia-Tech 🧠
from The Healthtech Podcast · host Dr. James Somauroo
James is joined by Sina Habibi, founder and CEO of AI dementia-tech startup, Cognetivity. Sina simplifies complex challenges and develops compelling and collaborative ways to solve them and in addition to business executive roles he has experience in research (nano-technology and synthetic biology), product management, and high-tech consultancy (big data and fin-tech). Sina has been an active member of Cambridge University Entrepreneurs (CUE) since 2010 and chaired the society in 2013-2014. Cognetivity has patented and pilot-tested a software-based platform technology for assessing mental health. Early diagnosis and management of cognitive disorders, including dementia, holds the promise of transforming peoples’ lives and bringing clarity to international healthcare management provision. The early diagnostic sector is starting to gain significant commercial interest as it offers metrics to the pharmaceutical industry in the development of new therapeutics. Additionally the markets for early screening and home monitoring offers significant health economic benefit to payors. https://www.cognetivity.com/
What this episode covers
James is joined by Sina Habibi, founder and CEO of AI dementia-tech startup, Cognetivity. Sina simplifies complex challenges and develops compelling and collaborative ways to solve them and in addition to business executive roles he has experience in research (nano-technology and synthetic biology), product management, and high-tech consultancy (big data and fin-tech). Sina has been an active member of Cambridge University Entrepreneurs (CUE) since 2010 and chaired the society in 2013-2014. Cognetivity has patented and pilot-tested a software-based platform technology for assessing mental health. Early diagnosis and management of cognitive disorders, including dementia, holds the promise of transforming peoples’ lives and bringing clarity to international healthcare management provision. The early diagnostic sector is starting to gain significant commercial interest as it offers metrics to the pharmaceutical industry in the development of new therapeutics. Additionally the markets for early screening and home monitoring offers significant health economic benefit to payors. https://www.cognetivity.com/
NOW PLAYING
Episode 25: The Story of Cognetivity and AI Dementia-Tech 🧠
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.